Implantable Collamer Lens or ICL is a intraocular lens that can be implanted into the eye without removing the natural lens. This lens is made from a material called Collamer, a collagen co-polymer that is stable and biocompatible, soft, flexible and highly safe. Since ICL is implanted through a microscopic incision that requires no stitches, it does not alter the natural shape or health of the cornea.
Gimbel was the first surgeon in America to offer the Implantable Collamer Lens (ICL) to his patients in 1997.
Whenever patients are fit for LASIK surgery, most surgeons recommend LASIK over ICL surgery because it has less risk and faster risk as compared to ICL. When patients are unfit for LASIK due to very high number or poor corneal thickness or shape, ICL surgery is indeed the best treatment option for the patient. ICL is only FDA-approved for patients between the ages of 21-45. The “lifetime” of the ICL collagen lens is estimated to be around 90 years in laboratories.
ICL eye surgery is done under a local anesthetic eyedrops, to numb the eyes. No injection and no patch is required. Yes, while this means that you are awake during the procedure, there is no pain, and patients are very comfortable throughout ICL surgery.
There are a few key characteristics that make a good candidate for ICL surgery: You are between 21 and 45 years old. You have nearsighted vision with mild to severe myopia (-3D to -20D).
In addition to improved vision, there are numerous benefits of an ICL: It can fix severe nearsightedness that can't be corrected with other surgeries. A Chances of dry eyes is less after this surgery, which is ideal if your eyes are chronically dry. It's meant to be permanent but can be removed.